If you are sourcing 1,4-Dioxaspiro[4,5]dec-7-en-8-boronic acid pinacol ester, CAS 680596-79-6, you are likely looking for a specialized boronic ester intermediate for medicinal chemistry, process development, or custom synthesis. I treat this material as a project-specific research and pharmaceutical intermediate rather than as a finished active pharmaceutical ingredient. The most important buying checks are identity confirmation, purity, packaging, storage guidance, available quantity, and the supplier’s ability to provide appropriate documentation.
Please visit our website for more information on this topic.
At Maison Chemical, I support B2B buyers who need to evaluate this compound for laboratory use, route development, scale-up planning, or recurring procurement. Because commercial specifications can differ by production route and application, I recommend confirming the required purity, analytical package, quantity, and delivery destination before requesting a formal quotation.
This guide is intended for pharmaceutical and biotechnology companies, contract research organizations, chemical distributors, academic laboratories, and procurement teams evaluating CAS 680596-79-6. It is also useful for process chemists who need a defined boronic ester building block for a synthetic route. Buyers should use the guide to structure technical questions before placing an order, not as a substitute for an internal chemical risk assessment.
I also recommend this approach for companies comparing several suppliers. A lower quoted price does not necessarily represent the lowest total cost if the material requires additional testing, arrives in unsuitable packaging, or cannot be supplied consistently for the next project stage.
1,4-Dioxaspiro[4,5]dec-7-en-8-boronic acid pinacol ester is a specialized organoboron compound identified by CAS Registry Number 680596-79-6. Its structure combines a boronic acid pinacol ester functionality with a spirocyclic dioxolane-containing ring system and an unsaturated position. These structural features make it relevant as a synthetic building block when a project requires controlled carbon–carbon bond formation involving an organoboron intermediate.
In practical terms, buyers often evaluate this compound for palladium-catalyzed cross-coupling development, especially Suzuki-type reactions, although the exact reaction suitability depends on the reaction partners, catalyst system, solvent, base, temperature, and work-up conditions. I do not recommend assuming that a successful small-scale reaction will automatically translate to manufacturing scale. The compound should be assessed within the complete route and under the customer’s own validated conditions.
The compound is generally considered a research or synthesis intermediate, not a finished drug substance. Its inclusion in a synthetic route does not by itself establish pharmaceutical suitability, regulatory acceptance, or clinical performance. I therefore encourage buyers to define the intended use before selecting a grade or documentation package.
For CAS 680596-79-6, the first specification to confirm is the exact chemical identity. I recommend checking the CAS number, product name, structure representation, lot-specific analytical data, and the supplier’s internal product code. If stereochemical, positional, or impurity requirements are important to your route, those requirements should be stated clearly in the inquiry rather than inferred from the product name.
| Buying parameter | What I recommend confirming |
|---|---|
| Identity | CAS 680596-79-6, structure, nomenclature, and lot traceability |
| Purity | Assay method, reported purity, related substances, and acceptance criteria |
| Analytical package | Certificate of analysis, NMR, LC-MS, HPLC or other applicable data |
| Physical form | Appearance, container type, net weight, and any special handling instructions |
| Logistics | Available stock, production lead time, shipping conditions, and export documents |
Purity should be discussed in relation to the application. A discovery-stage screening project may use a different acceptance range from a process-development campaign, while a regulated supply chain may require additional impurity characterization and documentation. I avoid treating a single percentage value as universally appropriate unless the buyer has provided a defined specification.
Start by identifying whether the material is needed for route discovery, analytical comparison, kilogram planning, or repeat production. Record the target quantity in a measurable unit, such as 100 mg, 1 g, or 1 kg, and state whether the first order is a sample, a development batch, or a commercial evaluation. This information helps the supplier assess packaging and production feasibility more accurately.
Ask for a representative certificate of analysis and available structural or chromatographic data before purchasing. Depending on the supplier and project stage, the package may include NMR, LC-MS, HPLC, water or residual-solvent information, and a safety data sheet. I recommend comparing the test methods as well as the reported results, because two suppliers may use different analytical conditions.
Link to Maison Chemical
A suitable supplier should explain whether the material is available from stock, produced on demand, or sourced through a manufacturing partner. Ask about minimum order quantity, batch availability, repeat-order consistency, and the expected lead time for the next purchase. For planning purposes, I suggest requesting both the initial delivery estimate and a separate estimate for a repeat order of the same quantity.
Confirm the container size, inner packaging, labeling, and recommended storage conditions. Boronic ester intermediates can require protection from moisture, heat, light, or prolonged exposure to unsuitable environments, but the correct requirements must come from the product-specific SDS and supplier documentation. I also recommend checking whether the shipping package is appropriate for the destination country and the customer’s receiving procedures.
The best supplier is not always the one offering the lowest unit price. I evaluate the combination of identity confidence, analytical transparency, batch availability, documentation quality, communication speed, and ability to support the customer’s expected scale. For a development program, a reliable small pack with clear data may be more valuable than a large quantity with limited documentation.
Pricing for CAS 680596-79-6 is normally quotation-based because it can vary with purity, quantity, packaging, production status, testing requirements, destination, and shipping terms. I recommend asking for at least two quantity tiers, such as a gram-scale option and a larger development quantity, so the buyer can compare the price curve without assuming that a higher volume is automatically economical.
Lead time should also be treated as a planning variable rather than a fixed product attribute. Stock status, batch release, analytical testing, export review, and destination requirements may all affect the final schedule. When a project has a fixed experiment date, I advise buyers to request written confirmation of the dispatch window and to maintain enough material for repeat testing where appropriate.
Another common mistake is evaluating only the first delivery. For route development, the second or third batch can be just as important because changes in impurity profile or availability may affect reproducibility. I recommend keeping the supplier’s lot documentation with the project records and discussing any material change before using a new batch in a critical comparison.
Maison Chemical serves B2B customers seeking specialized chemicals and pharmaceutical intermediates, including 1,4-Dioxaspiro[4,5]dec-7-en-8-boronic acid pinacol ester CAS 680596-79-6. I can help organize an inquiry around the required quantity, target specification, documentation, packaging, destination, and expected delivery schedule. This structured approach allows the quotation to reflect the actual project rather than a generic product listing.
For customers at different development stages, I can discuss sample evaluation, repeat procurement, and larger-volume planning subject to production and quality review. I do not recommend promising a specific quantity, purity, or delivery date until the technical and commercial details have been confirmed. The practical next step is to send the CAS number, requested amount, desired purity, application stage, destination country, and documentation requirements.
1,4-Dioxaspiro[4,5]dec-7-en-8-boronic acid pinacol ester CAS 680596-79-6 is a specialized organoboron intermediate that may support medicinal chemistry, cross-coupling research, and process-development programs. The most reliable buying decision combines identity verification, application-appropriate purity, lot-specific analytical data, suitable packaging, and realistic supply planning. I recommend treating price, MOQ, and lead time as quotation variables rather than fixed assumptions.
To move forward with Maison Chemical, prepare a concise purchasing brief covering the required quantity, specification, delivery destination, preferred packaging, and documents needed for internal approval. I can then help determine the appropriate supply route and provide a project-specific quotation for review. This gives your technical and procurement teams a clearer basis for approving CAS 680596-79-6.
For more 1,4-Dioxaspiro[4,5]dec-7-en-8-boronic acid pinacol ester CAS 680596-79-6information, please contact us. We will provide professional answers.